Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories share news and announcements
636 announcements, routine notices left out, newest first. Page 10 of 13.
Aug 2012
Jul 2012
24 Jul · Board meeting
Inter-alia, to consider and approve the unaudited financial results for the first quarter ended June 30, 2012.2 Jul · Dividend
Divi'S Laboratories Limited had informed the Exchange that dividend will be credited / dispatched on August 20, 2012. The Company has now informed the Exchange that the dividend payment date will be considered as August 21, 2012.2 Jul · Meeting
Share Transfer Books of the Company will remain closed from July 30, 2012 to August 03, 2012 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on August 06, 2012 and payment of Dividend, if declared at the ensuing Annual General Meeting. Further dividend will be credited / dispatched on August 20, 2012.
May 2012
12 May · Dividend
Board of Directors of the Company at its meeting held on May 12, 2012, has recommended a dividend of 650% i.e. Rs. 13/- per equity share of Rs. 2/- face value for the year ended March 31, 2012.4 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend Dividend on Equity Shares for the year ended March 31, 2012, if any.
Apr 2012
20 Apr · Disclosure of Voting Pattern - Clause 35A
19 Apr · Results
Audited Financial Results of the Company for the entire financial year 2011-2012 shall be considered and published by the company within the stipulated time period of sixty days from the end of the financial year i.e., on or before May 30, 2012. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on March 31, 2012.
Mar 2012
6 Mar · Business
Compensation Committee of Board of Directors on March 05, 2012 made the allotment of 31180 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132734290 equity shares from 132703110 equity shares of face value Rs. 2/- each.
Jan 2012
30 Jan · Management
Dr. P. Gundu Rao, Non-Executive Director of the Company has resigned from the Board as he relocated to the USA to spend time with his family. The Board has accepted his resignation and appreciated his constribution to the Company.18 Jan · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the third quarter ended December 31, 2011.
Nov 2011
1 Nov · Business
Compensation Committee of Board of Directors in its meeting held on November 01, 2011 made the allotment of 26560 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132703110 equity shares from 132676550 equity shares of face value Rs. 2/- each.
Oct 2011
21 Oct · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2011.
Sep 2011
Aug 2011
6 Aug · Business
Compensation Committee of Board of Directors in its meeting held on August 06, 2011 made the allotment of 26520 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132676550 equity shares from 132650030 equity shares of face value Rs. 2/- each.3 Aug · Updates
It has had an inspection by the US-FDA, with no major observations, for its Unit-I at Vill. Lingojigudem, Choutuppal Mandal near Hyderabad during July, 2011. The audit concluded with minor observations primarily about additional records for further improvement of existing records. The purpose of this inspection was for product pre-approval and general cGMP (Current Good Manufacturing Practices).
Jul 2011
26 Jul · Board meeting
Inter-alia, to consider and approve the un-audited financial results for the quarter ended June 30, 2011.
May 2011
27 May · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from June 18, 2011 to June 24, 2011 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on August 08, 2011 and payment of Dividend, if declared at the ensuing Annual General Meeting.23 May · Business
Compensation Committee of Board of Directors in its meeting held on May 20, 2011 made the allotment of 54920 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132650030 equity shares from 132595110 equity shares of face value Rs. 2/- each.23 May · Updates
Dr.P.Gundu Rao, Director (R&D) of the Company has resigned as whole-time Director of the Company effective June 01, 2011. Dr.Gundu Rao will, however, continue as a Non-Executive Director of the Company.23 May · Results
Standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 130544 lacs for year ending on 31-MAR-2011 against Rs. 92928 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 43557 lacs for the year ending on 31-MAR-2011 against Rs. 34420 lacs for the year ending on 31-MAR-2010.23 May · Results
Consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 130711 lacs for year ending on 31-MAR-2011 against Rs. 94161 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 42927 lacs for the year ending on 31-MAR-2011 against Rs. 34034 lacs for the year ending on 31-MAR-2010.23 May · Dividend
Board of Directors at its meeting held on May 20, 2011 has recommended a dividend of 500% i.e. Rs. 10/- per equity share of Rs. 2/- face value for the year ended March 31, 2011.6 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2011 and to recommend Dividend on Equity Shares for the Year ended March 31, 2011, if any.
Apr 2011
25 Apr · Results
Audited Financial Results of the Company for the entire financial year 2010-2011 shall be considered and published by the company within the stipulated time period of sixty days from the end of the financial year i.e., on or before May 30, 2011. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on March 31, 2011.4 Apr · Legal
Webcast in News channel on April 01, 2011 reporting that "Divi's Labs is looking to acquire US Biotech companies". The Company has clarified that there are no plans or discussions or negotiations to acquire any biotech Company or of any fund raising.
Feb 2011
4 Feb · Business
Compensation Committee of Board of Directors in its meeting held on February 4, 2011 made the allotment of 29690 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132595110 equity shares from 132565420 equity shares of face value Rs. 2/- each.4 Feb · Results
Consolidated Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 30969 lacs for quarter ending on 31-DEC-2010 against Rs. 19631 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 9842 lacs for the quarter ending on 31-DEC-2010 against Rs. 6784 lacs for the quarter ending on 31-DEC-2009.4 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 31005 lacs for quarter ending on 31-DEC-2010 against Rs. 18990 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 10157 lacs for the quarter ending on 31-DEC-2010 against Rs. 6879 lacs for the quarter ending on 31-DEC-2009.
Jan 2011
22 Jan · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the third quarter ended December 31, 2010.
Nov 2010
9 Nov · Business
Compensation Committee of Board of Directors in its meeting held on November 09, 2010 made the allotment of 34180 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132565420 equity shares from 132531240 equity shares of face value Rs.2/- each.9 Nov · Results
Consolidated Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 25531 lacs for quarter ending on 30-SEP-2010 against Rs. 22534 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 7193 lacs for the quarter ending on 30-SEP-2010 against Rs. 8479 lacs for the quarter ending on 30-SEP-2009.